Abstract

Osseointegration, defined as the direct structural and functional connection between living bone and the surface of a load-bearing implant, remains a cornerstone of successful dental and orthopedic implantology. Despite significant clinical success, challenges persist in achieving predictable osseointegration, particularly in patients with compromised bone quality, systemic diseases, or those requiring immediate loading protocols. This comprehensive review examines recent advancements in osseointegration research, with a focus on innovations in materials science and bioengineering that have emerged over the past decade. The paper explores the transformative impact of nanotechnology-based surface modifications, bioactive coatings, growth factor delivery systems, and stem cell therapies on enhancing bone-implant integration. By synthesizing current evidence from multiple disciplines, this review provides a detailed analysis of cutting-edge strategies designed to optimize the osseointegration process and expand the clinical applications of implant-based therapies. The integration of these advanced technologies holds significant promise for improving implant success rates, expanding treatment indications, and enhancing patient outcomes across diverse clinical scenarios.

**Keywords:** Osseointegration, nanotechnology, surface modification, growth factors, stem cell therapy, biomaterials, implant stability

---

1. Introduction

Osseointegration, first described by Per-Ingvar Brånemark in the 1960s, represents a fundamental biological phenomenon that has revolutionized the fields of dental and orthopedic implantology (1, 2). Defined as the direct structural and functional connection between ordered living bone and the surface of a load-bearing implant, osseointegration is essential for the long-term success and stability of implant-based reconstructions (3, 4). The process involves complex cellular and molecular interactions at the bone-implant interface, including protein adsorption, cell adhesion, proliferation, differentiation, and ultimately, the formation of new bone tissue directly apposed to the implant surface (5, 6).

Despite significant clinical success rates, challenges remain in achieving predictable osseointegration, particularly in patients with compromised bone quality, systemic diseases, or those requiring immediate loading protocols (7, 8). These limitations have driven extensive research efforts aimed at enhancing the biological response to implant materials and accelerating the osseointegration timeline (9, 10). Contemporary research focuses on manipulating implant surface characteristics, incorporating bioactive molecules, and leveraging regenerative medicine approaches to optimize bone-implant interactions (11, 12).

The past two decades have witnessed remarkable progress in materials science and bioengineering, providing new tools and strategies to enhance osseointegration (13, 14). This review examines recent advancements in osseointegration research, with particular emphasis on nanotechnology-based surface modifications, bioactive coatings, growth factor delivery systems, and stem cell therapies that hold promise for improving clinical outcomes in implant dentistry and orthopedic surgery. By synthesizing current evidence from multiple disciplines, this paper aims to provide a comprehensive overview of cutting-edge strategies designed to optimize the osseointegration process and expand the clinical applications of implant-based therapies.

---

2. Nanotechnology in Implant Surface Modification

2.1 Nanoscale Surface Topography

The application of nanotechnology to modify implant surface characteristics has emerged as one of the most promising strategies for enhancing osseointegration (15, 16). Nanoscale surface features, typically ranging from 1 to 100 nanometers, can significantly influence protein adsorption, cell adhesion, and osteoblast differentiation at the bone-implant interface (17, 18). Research has demonstrated that nanotopographical modifications can enhance osteoconductivity—the ability of a surface to support bone growth along its surface—and osteoinductivity—the capacity to induce bone formation from undifferentiated mesenchymal cells (19, 20).

Various techniques have been developed to create nanoscale surface features on titanium and titanium alloy implants, including anodization, acid etching, plasma spraying, and sol-gel deposition (21, 22). These methods produce diverse nanotopographies such as nanotubes, nanopits, nanogrooves, and nanoparticles, each with distinct effects on cellular behavior (23, 24). Studies have shown that nanostructured surfaces can enhance initial protein adsorption, promote osteoblast attachment and proliferation, and accelerate the differentiation of mesenchymal stem cells toward the osteogenic lineage (25, 26).

The nanoscale topography influences cellular responses through several mechanisms. Nanotopographical features can alter the conformation and orientation of adsorbed proteins, which in turn affects cell adhesion and signaling pathways (27). Nanotopography can also influence the cytoskeletal organization of cells, leading to changes in focal adhesion formation and activation of downstream signaling cascades (28). Furthermore, nanoscale features can modulate the expression of genes involved in osteogenic differentiation, such as Runx2, osteocalcin, and alkaline phosphatase (29, 30).

2.2 Nanocoatings and Bioactive Materials

Beyond topographical modifications, nanocoatings incorporating bioactive materials have demonstrated significant potential in promoting osseointegration (27, 28). Hydroxyapatite nanoparticles, calcium phosphate nanocrystals, and bioactive glass nanocomposites have been successfully applied to implant surfaces to enhance bioactivity and bone bonding (29, 30). These nanocoatings can provide a more biomimetic environment that closely resembles the natural bone mineral composition, thereby facilitating cellular recognition and bone formation (31, 32).

Hydroxyapatite (HA) is the primary inorganic component of natural bone and has been extensively studied for its osteoconductive properties (33, 34). Nanoscale HA coatings have been shown to enhance osteoblast adhesion, proliferation, and differentiation compared to microscale HA coatings (35, 36). The increased surface area and improved wettability of nanoscale HA coatings contribute to enhanced protein adsorption and cellular interactions (37, 38).

Calcium phosphate (CaP) nanomaterials, including tricalcium phosphate (TCP) and biphasic calcium phosphate (BCP), have also been investigated for their ability to promote bone regeneration (39, 40). These materials can release calcium and phosphate ions that stimulate osteoblast activity and promote mineralization (41, 42). The combination of different calcium phosphate phases in BCP coatings can provide a balance between resorbability and bioactivity, allowing for gradual replacement by natural bone tissue (43, 44).

Bioactive glass nanocomposites represent another promising approach for enhancing osseointegration (45, 46). These materials can release ions such as calcium, phosphorus, and silicon, which have been shown to stimulate osteoblast proliferation and differentiation (47, 48). The release of these ions can also promote angiogenesis, which is crucial for the formation of new bone tissue (49, 50).

2.3 Advanced Nanofabrication Techniques

Recent advancements in nanofabrication techniques have enabled the development of more sophisticated and functional implant surfaces. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and electrochemical anodization have allowed for precise control over the thickness, composition, and structure of nanocoatings (51, 52). These techniques can produce coatings with tailored properties, such as specific surface energy, wettability, and mechanical strength, to optimize their interaction with biological tissues (53, 54).

For example, ALD allows for the deposition of ultra-thin, conformal coatings with precise control over thickness and composition (55, 56). This technique has been used to create nanocoatings of titanium dioxide (TiO₂) and other metal oxides that can enhance protein adsorption and cell adhesion (57, 58). CVD techniques can produce coatings with high purity and excellent adhesion to the substrate, making them suitable for applications requiring high chemical stability (59, 60).

Electrochemical anodization has been widely used to create nanotubular structures on titanium surfaces (61, 62). This technique involves the electrochemical oxidation of titanium in an electrolyte solution, resulting in the formation of highly ordered nanotube arrays (63, 64). The diameter, length, and wall thickness of these nanotubes can be precisely controlled by adjusting the anodization parameters, allowing for the optimization of cellular responses (65, 66).

---

3. Growth Factors and Biological Enhancement

3.1 Growth Factor Delivery Systems

The application of growth factors represents a biological approach to enhancing osseointegration by directly stimulating cellular activities involved in bone regeneration (33, 34). Key growth factors that have been investigated include bone morphogenetic proteins (BMPs), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β) (35, 36). These molecules play critical roles in regulating mesenchymal stem cell differentiation, osteoblast proliferation, angiogenesis, and extracellular matrix synthesis (37, 38).

Bone morphogenetic proteins (BMPs) are a family of signaling molecules that belong to the transforming growth factor-beta (TGF-β) superfamily (67, 68). BMPs have been shown to induce osteoblast differentiation and bone formation through the activation of Smad signaling pathways (69, 70). BMP-2 and BMP-7 are the most extensively studied BMPs in the context of bone regeneration and have been approved by the FDA for specific clinical applications (71, 72).

Platelet-derived growth factor (PDGF) is another important growth factor that has been investigated for its role in bone healing (73, 74). PDGF promotes the proliferation and migration of mesenchymal stem cells and osteoblasts, and it also stimulates angiogenesis, which is essential for the formation of new bone tissue (75, 76). PDGF has been shown to enhance bone regeneration in various animal models and clinical settings (77, 78).

Vascular endothelial growth factor (VEGF) plays a crucial role in angiogenesis, the formation of new blood vessels, which is essential for the survival and function of newly formed bone tissue (79, 80). VEGF can stimulate the proliferation and migration of endothelial cells, leading to the formation of new capillaries that supply oxygen and nutrients to the developing bone tissue (81, 82).

3.2 Controlled Delivery Systems

Controlled delivery of growth factors to the implant site remains a significant challenge, as these proteins are susceptible to rapid degradation and diffusion in the physiological environment (39, 40). Recent research has focused on developing sophisticated delivery systems, including polymer-based carriers, hydrogels, and surface-immobilized growth factors, to achieve sustained and localized release at therapeutic concentrations (41, 42).

Polymer-based carriers, such as poly(lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG), have been widely used for the controlled release of growth factors (83, 84). These polymers can be engineered to degrade at specific rates, allowing for the sustained release of growth factors over several weeks (85, 86). For example, PLGA microspheres have been used to deliver BMP-2 in a controlled manner, resulting in enhanced bone formation and improved implant stability (87, 88).

Hydrogels represent another promising approach for growth factor delivery (89, 90). These three-dimensional networks of hydrophilic polymers can encapsulate growth factors and release them in a controlled manner through diffusion or degradation (91, 92). Hydrogels can be designed to respond to specific stimuli, such as changes in pH, temperature, or enzymatic activity, allowing for the development of smart delivery systems that release growth factors in response to specific biological cues (93, 94).

Surface-immobilized growth factors offer the advantage of localized delivery and reduced systemic exposure (95, 96). By covalently attaching growth factors to the implant surface, researchers can ensure that the growth factors remain at the site of interest and are presented to cells in a bioactive form (97, 98). This approach can enhance the local concentration of growth factors and reduce the risk of adverse effects associated with systemic administration (99, 100).

3.3 Clinical Applications and Outcomes

Clinical studies investigating growth factor applications in implant therapy have shown promising results, particularly in challenging clinical scenarios such as immediate implant placement, sinus augmentation, and treatment of peri-implant bone defects (43, 44). However, optimal dosing, delivery methods, and combination strategies remain areas of active investigation (45).

For example, the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance bone formation in sinus augmentation procedures, resulting in improved implant success rates (101, 102). In a randomized controlled trial, patients who received rhBMP-2 in combination with a collagen sponge demonstrated significantly greater bone volume and implant stability compared to those who received a collagen sponge alone (103, 104).

Similarly, the application of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) has been investigated for their ability to deliver growth factors in a concentrated form (105, 106). PRP and PRF contain high concentrations of growth factors, including PDGF, TGF-β, and VEGF, which can stimulate bone regeneration and enhance osseointegration (107, 108). Clinical studies have shown that the use of PRP and PRF can improve implant success rates and reduce the risk of implant failure (109, 110).

---

4. Stem Cell Therapy and Regenerative Approaches

4.1 Mesenchymal Stem Cells in Bone Regeneration

Stem cell therapy represents a cutting-edge approach to regenerating bone tissue and improving osseointegration, particularly in cases of poor bone quality or quantity (46, 47). Mesenchymal stem cells (MSCs), derived from bone marrow, adipose tissue, or dental pulp, possess the capacity for self-renewal and multilineage differentiation, including osteogenic, chondrogenic, and adipogenic pathways (48, 49). When appropriately stimulated, MSCs can differentiate into osteoblasts and contribute directly to new bone formation at the implant interface (50, 51).

Research has explored various strategies for incorporating stem cells into implant therapy, including pre-seeding implant surfaces with MSCs, combining stem cells with scaffold materials, and using cell-derived extracellular vesicles to deliver osteogenic signals (52, 53). These approaches aim to enhance the regenerative capacity of the local tissue environment and accelerate the osseointegration process (54, 55).

4.2 Scaffold Materials and 3D Printing

Scaffold materials play a crucial role in stem cell therapy by providing a three-dimensional structure that supports cell attachment, proliferation, and differentiation (111, 112). Various materials have been investigated for their use as scaffolds in bone tissue engineering, including natural polymers such as collagen and chitosan, and synthetic polymers such as poly(lactic acid) (PLA) and poly(glycolic acid) (PGA) (113, 114).

3D printing technologies have enabled the fabrication of complex scaffold structures with precise control over pore size, porosity, and architecture (115, 116). This allows for the optimization of scaffold properties to promote cell infiltration, nutrient diffusion, and vascularization (117, 118). For example, 3D-printed scaffolds made from biocompatible materials such as polycaprolactone (PCL) and hydroxyapatite have been shown to support MSC attachment and differentiation into osteoblasts (119, 120).

4.3 Clinical Applications and Outcomes

Clinical studies investigating stem cell therapy for bone regeneration have shown promising results, particularly in the treatment of bone defects and nonunions (121, 122). For example, a randomized controlled trial demonstrated that the use of autologous bone marrow aspirate concentrate (BMAC) in combination with a calcium sulfate scaffold resulted in improved bone healing and implant stability in patients with critical-sized bone defects (123, 124).

Similarly, the use of adipose-derived stem cells (ADSCs) has been investigated for their ability to enhance bone regeneration in various clinical settings (125, 126). ADSCs have been shown to promote osteogenic differentiation and enhance bone formation in animal models and clinical trials (127, 128).

---

5. Conclusion

Osseointegration research has experienced remarkable progress through innovations in materials science and bioengineering. Nanotechnology-based surface modifications have demonstrated significant potential in enhancing osteoconductivity and osteoinductivity by creating biomimetic interfaces that promote favorable cellular responses. The strategic application of growth factors and development of sophisticated delivery systems offer biological enhancement of bone regeneration at implant sites. Furthermore, stem cell therapy holds considerable promise for regenerating bone tissue and improving osseointegration outcomes, particularly in challenging clinical scenarios involving compromised bone quality.

The convergence of these technological advancements—nanoscale surface engineering, biological enhancement through growth factors, and regenerative medicine approaches—represents a paradigm shift in implant therapy. Future research should focus on optimizing combination strategies that synergistically integrate these innovations, conducting rigorous clinical trials to validate efficacy and safety, and developing personalized approaches tailored to individual patient characteristics. As these technologies mature and transition from laboratory research to clinical application, they hold the potential to significantly improve implant success rates, expand treatment indications, and enhance patient outcomes across diverse clinical scenarios.

Versi Bahasa Indonesia

Kemajuan Baru dalam Riset Oseointegrasi

Abstrak

Osseointegrasi, yang didefinisikan sebagai koneksi langsung struktural dan fungsional antara tulang hidup dan permukaan implan yang menahan beban, tetap menjadi fokus utama dalam ilmu kedokteran gigi dan ortopedi. Meskipun telah mencapai tingkat keberhasilan klinis yang tinggi, tantangan masih ada dalam mencapai osseointegrasi yang dapat diandalkan, terutama pada pasien dengan kualitas tulang yang terganggu, penyakit sistemik, atau mereka yang membutuhkan protokol pemuatan langsung (immediate loading) (1, 2). Penelitian ini meninjau kemajuan terkini dalam penelitian osseointegrasi, dengan fokus khusus pada inovasi dalam ilmu material dan bio teknologi yang telah muncul selama dekade terakhir. Pendekatan baru termasuk modifikasi permukaan implan berbasis nanoteknologi, lapisan bioaktif, pengiriman faktor pertumbuhan, dan terapi sel stem yang berpotensi meningkatkan proses penyembuhan tulang dan stabilitas implan. Dengan menyintesis bukti saat ini dari berbagai disiplin ilmu, tinjauan ini memberikan gambaran komprehensif tentang strategi mutakhir yang dirancang untuk mengoptimalkan proses osseointegrasi dan memperluas aplikasi klinis terapi berbasis implan.

**Kata kunci:** Osseointegrasi, nanoteknologi, modifikasi permukaan, faktor pertumbuhan, terapi sel stem, biomaterial, stabilitas implan

1. Pendahuluan

Osseointegrasi, yang pertama kali dijelaskan oleh Per-Ingvar Brånemark pada 1960-an, mewakili fenomena biologis yang telah merevolusi bidang ilmu kedokteran gigi dan ortopedi (3, 4). Didefinisikan sebagai koneksi langsung struktural dan fungsional antara tulang hidup yang teratur dan permukaan implan yang menahan beban, osseointegrasi sangat penting untuk keberhasilan jangka panjang dan stabilitas rekonstruksi berbasis implan (5, 6). Proses ini melibatkan interaksi seluler dan molekuler yang kompleks di antarmuka tulang-implan, termasuk adsorpsi protein, adhesi sel, proliferasi, diferensiasi, dan akhirnya pembentukan jaringan tulang baru yang langsung berdekatan dengan permukaan implan (7, 8).

Meskipun telah mencapai tingkat keberhasilan klinis yang tinggi, tantangan masih ada dalam mencapai osseointegrasi yang dapat diandalkan, terutama pada pasien dengan kualitas tulang yang terganggu, penyakit sistemik, atau mereka yang membutuhkan protokol pemuatan langsung (immediate loading) (9, 10). Tantangan ini telah mendorong upaya penelitian yang luas untuk meningkatkan respons biologis terhadap bahan implan dan mempercepat proses osseointegrasi (11, 12). Penelitian kontemporer berfokus pada memanipulasi karakteristik permukaan implan, mengintegrasikan molekul bioaktif, dan memanfaatkan pendekatan rekayasa jaringan untuk mengoptimalkan interaksi tulang-implan (13, 14).

Dua dekade terakhir telah menyaksikan kemajuan luar biasa dalam ilmu material dan bio teknologi, menyediakan alat dan strategi baru untuk meningkatkan osseointegrasi (15, 16). Tinjauan ini mengeksplorasi kemajuan terkini dalam penelitian osseointegrasi, dengan penekanan khusus pada teknik berbasis nanoteknologi, lapisan bioaktif, sistem pengiriman faktor pertumbuhan, dan terapi sel stem yang berpotensi meningkatkan hasil klinis dalam ilmu kedokteran gigi dan ortopedi.

2. Nanoteknologi dalam Modifikasi Permukaan Implan

2.1 Topografi Permukaan Nanoskala

Penerapan nanoteknologi untuk memodifikasi karakteristik permukaan implan telah muncul sebagai salah satu pendekatan yang paling menjanjikan untuk meningkatkan osseointegrasi (17, 18). Fitur permukaan nanoskala, yang biasanya berkisar dari 1 hingga 100 nanometer, dapat secara signifikan memengaruhi adsorpsi protein, adhesi sel, dan diferensiasi osteoblas di antarmuka tulang-implan (19, 20). Penelitian telah menunjukkan bahwa modifikasi topografi nanoskala dapat meningkatkan osteoconductivity—kemampuan permukaan untuk mendukung pertumbuhan tulang di sepanjang permukaannya—dan osteoinduktivity—kapasitas untuk menginduksi pembentukan tulang dari sel mesenkimal yang belum diferensiasi (21, 22).

Berbagai teknik telah dikembangkan untuk menciptakan fitur permukaan nanoskala pada implan titanium dan paduan titanium, termasuk anodisasi, pengasaman, penyemprotan plasma, dan deposisi sol-gel (23, 24). Teknik-teknik ini menghasilkan berbagai topografi nanoskala seperti nanotube, nanopits, nanogrooves, dan nanopartikel, masing-masing dengan efek yang berbeda pada perilaku sel (25, 26). Studi telah menunjukkan bahwa permukaan berstruktur nano dapat meningkatkan adsorpsi protein awal, mempromosikan adhesi dan proliferasi osteoblas, serta mempercepat diferensiasi sel stem mesenkimal ke arah jalur osteogenik (27, 28).

2.2 Nanolapisan dan Material Bioaktif

Selain modifikasi topografi, nanolapisan yang mengandung material bioaktif telah menunjukkan potensi signifikan dalam meningkatkan osseointegrasi (29, 30). Nanopartikel hidroksiapatit, kristal kalsium fosfat, dan komposit kaca bioaktif telah berhasil diterapkan pada permukaan implan untuk meningkatkan bioaktivitas dan ikatan tulang (31, 32). Lapisan-lapisan ini dapat menyediakan lingkungan yang lebih biomimetik yang menyerupai komposisi mineral tulang alami, sehingga memfasilitasi pengenalan sel dan pembentukan tulang (33, 34).

Hidroksiapatit (HA) adalah komponen inorganik utama dari tulang alami dan telah banyak diteliti untuk sifat osteoconductifnya (35, 36). Lapisan HA nanoskala telah ditunjukkan meningkatkan adhesi, proliferasi, dan diferensiasi osteoblas dibandingkan dengan lapisan HA mikroskala (37, 38). Area permukaan yang lebih besar dan wettability yang lebih baik dari lapisan HA nanoskala berkontribusi pada peningkatan adsorpsi protein dan interaksi sel (39, 40).

Kalsium fosfat (CaP) nanomaterial, termasuk tricalcium phosphate (TCP) dan biphasic calcium phosphate (BCP), juga telah diteliti untuk kemampuannya mempromosikan regenerasi tulang (41, 42). Material-material ini dapat melepaskan ion-ion seperti kalsium dan fosfat yang telah ditunjukkan merangsang proliferasi dan diferensiasi osteoblas (43, 44). Kombinasi berbagai fase kalsium fosfat dalam lapisan BCP dapat memberikan keseimbangan antara resorbsi dan bioaktivitas, memungkinkan penggantian bertahap oleh jaringan tulang alami (45, 46).

2.3 Teknologi Pemrosesan Nanomaju

Kemajuan terbaru dalam teknik pemrosesan nanomaju telah memungkinkan pengembangan permukaan implan yang lebih canggih dan fungsional. Teknik seperti deposisi lapisan atom (ALD), deposisi uap kimia (CVD), dan anodisasi elektrokimia telah digunakan untuk menciptakan lapisan nanoskala dengan kontrol presisi atas ketebalan, komposisi, dan struktur (47, 48). Teknik-teknik ini dapat menghasilkan lapisan dengan sifat yang terperinci, seperti energi permukaan, wettability, dan kekuatan mekanik, untuk mengoptimalkan interaksinya dengan jaringan biologis (49, 50).

Sebagai contoh, ALD memungkinkan deposisi lapisan ultra-tipis dengan kontrol presisi atas ketebalan dan komposisi (51, 52). Teknik ini telah digunakan untuk menciptakan lapisan nanoskala titanium dioksida (TiO₂) dan oksida logam lainnya yang dapat meningkatkan adsorpsi protein dan adhesi sel (53, 54). Teknik CVD dapat menghasilkan lapisan dengan kemurnian tinggi dan adhesi yang sangat baik terhadap substrat, menjadikannya cocok untuk aplikasi yang membutuhkan stabilitas kimia tinggi (55, 56).

Anodisasi elektrokimia telah banyak digunakan untuk menciptakan struktur nanotube pada permukaan titanium (57, 58). Teknik ini melibatkan oksidasi elektrokimia titanium dalam larutan elektrolit, menghasilkan pembentukan array nanotube yang sangat teratur (59, 60). Diameter, panjang, dan ketebalan dinding nanotube ini dapat dikontrol secara presisi dengan menyesuaikan parameter anodisasi, memungkinkan optimasi respons seluler (61, 62).

---

3. Faktor Pertumbuhan dan Peningkatan Biologis

3.1 Sistem Pengiriman Faktor Pertumbuhan

Penerapan faktor pertumbuhan mewakili pendekatan biologis untuk meningkatkan osseointegrasi dengan secara langsung merangsang aktivitas seluler yang terlibat dalam regenerasi tulang (63, 64). Faktor pertumbuhan utama yang telah diteliti termasuk protein morfogen tulang (BMPs), faktor pertumbuhan dari trombosit (PDGF), faktor pertumbuhan vaskular endotel (VEGF), dan faktor pertumbuhan transformasi (TGF-β) (65, 66). Molekul-molekul ini memainkan peran penting dalam mengatur diferensiasi sel stem mesenkimal, proliferasi osteoblas, angiogenesis, dan sintesis matriks ekstraseluler (67, 68).

Protein morfogen tulang (BMPs) adalah keluarga molekul sinyal yang termasuk dalam keluarga super TGF-β (69, 70). BMPs telah ditunjukkan merangsang diferensiasi osteoblas dan pembentukan tulang melalui aktivasi jalur sinyal Smad (71, 72). BMP-2 dan BMP-7 adalah BMP yang paling banyak diteliti dalam konteks regenerasi tulang dan telah disetujui oleh FDA untuk aplikasi klinis tertentu (73, 74).

Faktor pertumbuhan dari trombosit (PDGF) adalah faktor pertumbuhan penting lainnya yang telah diteliti untuk perannya dalam penyembuhan tulang (75, 76). PDGF mempromosikan proliferasi dan migrasi sel stem mesenkimal dan osteoblas, serta merangsang angiogenesis, yang penting untuk kelangsungan hidup dan fungsi jaringan tulang yang baru terbentuk (77, 78). PDGF telah ditunjukkan meningkatkan regenerasi tulang dalam berbagai model hewan dan pengaturan klinis (79, 80).

Faktor pertumbuhan vaskular endotel (VEGF) memainkan peran penting dalam angiogenesis, pembentukan pembuluh darah baru, yang penting untuk kelangsungan hidup dan fungsi jaringan tulang yang baru terbentuk (81, 82). VEGF dapat merangsang proliferasi dan migrasi sel endotel, menghasilkan pembentukan kapiler baru yang menyuplai oksigen dan nutrisi ke jaringan tulang yang sedang berkembang (83, 84).

3.2 Sistem Pengiriman Terkendali

Pengiriman terkendali faktor pertumbuhan ke situs implan tetap menjadi tantangan signifikan, karena protein ini rentan terhadap degradasi cepat dan difusi dalam lingkungan fisiologis (85, 86). Penelitian terkini telah berfokus pada pengembangan sistem pengiriman yang canggih, termasuk pembawa berbasis polimer, hidrogel, dan faktor pertumbuhan yang terikat pada permukaan, untuk mencapai pelepasan berkelanjutan dan lokal pada konsentrasi terapeutik (87, 88).

Pembawa berbasis polimer, seperti poli(laktida-co-glikolida) (PLGA) dan poli(ethylene glycol) (PEG), telah banyak digunakan untuk pengiriman faktor pertumbuhan (89, 90). Polimer-polimer ini dapat direkayasa untuk terdegradasi pada tingkat tertentu, memungkinkan pelepasan faktor pertumbuhan yang terkendali selama beberapa minggu (91, 92). Misalnya, mikrosfer PLGA telah digunakan untuk mengirimkan BMP-2 secara terkendali, menghasilkan peningkatan pembentukan tulang dan stabilitas implan yang lebih baik (93, 94).

Hidrogel mewakili pendekatan lain yang menjanjikan untuk pengiriman faktor pertumbuhan (95, 96). Jaringan tiga dimensi dari polimer hidrofilik ini dapat mengemas faktor pertumbuhan dan melepaskannya secara terkendali melalui difusi atau degradasi (97, 98). Hidrogel dapat dirancang untuk merespons rangsangan spesifik, seperti perubahan pH, suhu, atau aktivitas enzim, memungkinkan pengembangan sistem cerdas yang melepaskan faktor pertumbuhan sebagai respons terhadap sinyal biologis tertentu (99, 100).

Faktor pertumbuhan yang terikat pada permukaan menawarkan keuntungan dari pengiriman lokal dan mengurangi paparan sistemik (101, 102). Dengan mengikat secara kovalen faktor pertumbuhan ke permukaan implan, para peneliti dapat memastikan bahwa faktor pertumbuhan tetap di lokasi yang diinginkan dan disajikan kepada sel dalam bentuk bioaktif (103, 104). Pendekatan ini dapat meningkatkan konsentrasi lokal faktor pertumbuhan dan mengurangi risiko efek samping yang terkait dengan pemberian sistemik (105, 106).

3.3 Aplikasi Klinis dan Hasil

Studi klinis yang menyelidiki aplikasi faktor pertumbuhan dalam terapi implan telah menunjukkan hasil yang menjanjikan, terutama dalam skenario klinis yang menantang seperti pemasangan implan langsung, augmentasi sinus, dan pengobatan defek tulang peri-implan (107, 108). Namun, dosis optimal, metode pengiriman, dan strategi kombinasi tetap menjadi bidang penelitian aktif (109, 110).

Misalnya, penggunaan protein morfogen tulang rekombinan manusia-2 (rhBMP-2) telah ditunjukkan meningkatkan pembentukan tulang dalam prosedur augmentasi sinus, menghasilkan tingkat keberhasilan implan yang lebih baik (111, 112). Dalam sebuah uji coba terkontrol acak, pasien yang menerima rhBMP-2 dalam kombinasi dengan spons kolagen menunjukkan volume tulang yang lebih besar dan stabilitas implan yang lebih baik dibandingkan mereka yang menerima spons kolagen saja (113, 114).

Demikian pula, penerapan plasma kaya trombosit (PRP) dan fibrin kaya trombosit (PRF) telah diteliti untuk kemampuannya mengirimkan faktor pertumbuhan dalam bentuk terkonsentrasi (115, 116). PRP dan PRF mengandung konsentrasi tinggi faktor pertumbuhan, termasuk PDGF, TGF-β, dan VEGF, yang dapat merangsang regenerasi tulang dan meningkatkan osseointegrasi (117, 118). Studi klinis telah menunjukkan bahwa penggunaan PRP dan PRF dapat meningkatkan tingkat keberhasilan implan dan mengurangi risiko kegagalan implan (119, 120).

---

4. Terapi Sel Stem dan Pendekatan Regeneratif

4.1 Sel Stem Mesenkimal dalam Regenerasi Tulang

Terapi sel stem mewakili pendekatan mutakhir untuk meregenerasi jaringan tulang dan meningkatkan osseointegrasi, terutama dalam kasus-kasus dengan kualitas tulang yang buruk atau jumlah yang terbatas (121, 122). Sel stem mesenkimal (MSCs), yang berasal dari sumsum tulang, jaringan lemak, atau pulpa gigi, memiliki kapasitas untuk memperbarui diri sendiri dan diferensiasi ke berbagai jalur, termasuk osteogenik, chondrogenik, dan adipogenik (123, 124). Ketika dirangsang secara tepat, MSCs dapat diferensiasi menjadi osteoblas dan berkontribusi secara langsung pada pembentukan tulang baru di antarmuka implan (125, 126).

Penelitian telah mengeksplorasi berbagai strategi untuk mengintegrasikan sel stem ke dalam terapi implan, termasuk penuaan permukaan implan dengan MSCs, menggabungkan sel stem dengan bahan kerangka, dan menggunakan vesikel ekstraseluler yang berasal dari sel untuk mengirimkan sinyal osteogenik (127, 128). Pendekatan-pendekatan ini bertujuan untuk meningkatkan kapasitas regeneratif lingkungan jaringan lokal dan mempercepat proses osseointegrasi (129, 130).

4.2 Bahan Kerangka dan Pencetakan 3D

Bahan kerangka memainkan peran penting dalam terapi sel stem dengan menyediakan struktur tiga dimensi yang mendukung adhesi, proliferasi, dan diferensiasi sel (131, 132). Berbagai material telah diteliti untuk penggunaannya sebagai kerangka dalam rekayasa jaringan tulang, termasuk polimer alami seperti kolagen dan kitosan, serta polimer sintetis seperti poli(laktida) (PLA) dan poli(glikolida) (PGA) (133, 134).

Teknologi pencetakan 3D telah memungkinkan pembuatan struktur kerangka kompleks dengan kontrol presisi atas ukuran pori, porositas, dan arsitektur (135, 136). Ini memungkinkan optimalisasi sifat kerangka untuk mendukung infiltrasi sel, difusi nutrisi, dan vaskularisasi (137, 138). Misalnya, kerangka yang dicetak 3D dari bahan biokompatibel seperti polikaprolaktone (PCL) dan hidroksiapatit telah ditunjukkan mendukung adhesi dan diferensiasi MSCs menjadi osteoblas (139, 140).

4.3 Aplikasi Klinis dan Hasil

Studi klinis yang menyelidiki terapi sel stem untuk regenerasi tulang telah menunjukkan hasil yang menjanjikan, terutama dalam pengobatan defek tulang dan nonunions (141, 142). Misalnya, sebuah uji coba terkontrol acak menunjukkan bahwa penggunaan konsentrat sumsum tulang autolog (BMAC) dalam kombinasi dengan kerangka kalsium sulfat menghasilkan penyembuhan tulang yang lebih baik dan stabilitas implan yang lebih baik pada pasien dengan defek tulang kritis (143, 144).

Demikian pula, penerapan sel stem dari jaringan lemak (ADSCs) telah diteliti untuk kemampuannya meningkatkan regenerasi tulang dalam berbagai pengaturan klinis (145, 146). ADSCs telah ditunjukkan merangsang diferensiasi osteogenik dan meningkatkan pembentukan tulang dalam model hewan dan uji coba klinis (147, 148).

---

5. Kesimpulan

Penelitian osseointegrasi telah mengalami kemajuan luar biasa melalui inovasi dalam ilmu material dan bio teknologi. Modifikasi permukaan berbasis nanoteknologi telah menunjukkan potensi signifikan dalam meningkatkan osteoconductivity dan osteoinductivity dengan menciptakan antarmuka biomimetik yang mempromosikan respons sel yang menguntungkan. Pengembangan sistem pengiriman faktor pertumbuhan yang canggih menawarkan peningkatan biologis pada regenerasi tulang di situs implan. Selain itu, terapi sel stem berpotensi besar untuk meregenerasi jaringan tulang dan meningkatkan hasil osseointegrasi, terutama dalam skenario klinis yang menantang yang melibatkan kualitas tulang yang buruk.

Konvergensi dari teknologi-teknologi ini—rekayasa permukaan nanoskala, peningkatan biologis melalui faktor pertumbuhan, dan pendekatan rekayasa jaringan—mewakili perubahan paradigma dalam terapi implan. Penelitian masa depan harus fokus pada mengoptimalkan strategi kombinasi yang secara sinergis mengintegrasikan inovasi ini, melakukan uji coba klinis yang ketat untuk memvalidasi efikasi dan keamanan, serta mengembangkan pendekatan yang dipersonalisasi yang disesuaikan dengan karakteristik individu pasien. Seiring teknologi ini matang dan bertransisi dari penelitian laboratorium ke aplikasi klinis, mereka memiliki potensi untuk secara signifikan meningkatkan tingkat keberhasilan implan, memperluas indikasi perawatan, dan meningkatkan hasil pasien di berbagai skenario klinis.

Bibliography

1. Brånemark PI, Adell R, Breine U, Hansson BO, Lindström J, Ohlsson A. Intra-osseous anchorage of dental prostheses: I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3(2):81-100.

2. Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants: requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand. 1981;52(2):155-170.

3. Mavrogenis AF, Dimitriou R, Parvizi J, Babis GC. Biology of implant osseointegration. J Musculoskelet Neuronal Interact. 2009;9(2):61-71.

4. Dohan Ehrenfest DM, Coelho PG, Kang BS, Sul YT, Albrektsson T. Classification of osseointegrated implant surfaces: materials, chemistry and topography. Trends Biotechnol. 2010;28(4):198-206.

5. Gittens RA, Scheideler L, Rupp F, Hyzy SL, Geis-Gerstorfer J, Schwartz Z, et al. A review on the wettability of dental implant surfaces II: biological and clinical aspects. Acta Biomater. 2014;10(7):2907-2918.

6. Davies JE. Understanding peri-implant endosseous healing. J Dent Educ. 2003;67(8):932-949.

7. Javed F, Romanos GE. The role of primary stability for successful immediate loading of dental implants: a literature review. J Dent. 2010;38(8):612-620.

8. Chrcanovic BR, Albrektsson T, Wennerberg A. Bone quality and quantity and dental implant failure: a systematic review and meta-analysis. Int J Prosthodont. 2017;30(3):219-237.

9. Le Guéhennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23(7):844-854.

10. Smeets R, Stadlinger B, Schwarz F, Beck-Broichsitter B, Jung O, Precht C, et al. Impact of dental implant surface modifications on osseointegration. Biomed Res Int. 2016;2016:6285620.

11. Wennerberg A, Albrektsson T. Effects of titanium surface topography on bone integration: a systematic review. Clin Oral Implants Res. 2009;20 Suppl 4:172-184.

12. Girod SC, Teschner M, Schicho K, Maier T, Kevekordes B, Krol Z. New possibilities for tracking and navigation in endoscopic sinus surgery with the use of a surgical assistance system. Laryngorhinootologie. 2012;91(5):308-315.

13. Jemat A, Ghazali MJ, Razali M, Otsuka Y. Surface modifications and their effects on titanium dental implants. Biomed Res Int. 2015;2015:791725.

14. Chen Z, Mao X, Tan L, Friis T, Wu C, Crawford R, et al. Osteoimmunomodulatory properties of magnesium scaffolds coated with β-tricalcium phosphate. Biomaterials. 2014;35(30):8553-8565.

15. Mendonça G, Mendonça DB, Aragão FJ, Cooper LF. Advancing dental implant surface technology: from micron- to nanotopography. Biomaterials. 2008;29(28):3822-3835.

16. Kulkarni M, Mazare A, Gongadze E, Perutkova Š, Kralj-Iglič V, Milošev I, et al. Titanium nanostructures for biomedical applications. Nanotechnology. 2015;26(6):062002.

17. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials. 2004;25(19):4731-4739.

18. Zhao L, Mei S, Chu PK, Zhang Y, Wu Z. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials. 2010;31(19):5072-5082.

19. Sjöström T, Dalby MJ, Hart A, Tare R, Oreffo RO, Su B. Fabrication of pillar-like titania nanostructures on titanium and their interactions with human skeletal stem cells. Acta Biomater. 2009;5(5):1433-1441.

20. Puckett SD, Taylor E, Raimondo T, Webster TJ. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials. 2010;31(4):706-713.

21. Sul YT, Johansson CB, Petronis S, Krozer A, Jeong Y, Wennerberg A, et al. Characteristics of the surface oxides on turned and electrochemically oxidized pure titanium implants up to dielectric breakdown: the oxide thickness, micropore configurations, surface roughness, crystal structure and chemical composition. Biomaterials. 2002;23(2):491-501.

22. Liu X, Chu PK, Ding C. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater Sci Eng R Rep. 2004;47(3-4):49-121.

23. Popat KC, Leoni L, Gadegaard N, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials. 2007;28(21):3188-3197.

24. Brammer KS, Oh S, Cobb CJ, Bjursten LM, van der Heyde H, Jin S. Improved bone-forming functionality on diameter-controlled TiO₂ nanotube surface. Acta Biomater. 2009;5(8):3215-3223.

25. Oh S, Brammer KS, Li YS, Teng D, Engler AJ, Chien S, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A. 2009;106(7):2130-2135.

26. Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P, et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 2007;6(12):997-1003.

27. Huang Y, Qiu X, Zhang S, Huang Z, Qi J, Xu J, et al. Bioinspired topography-driven osteogenic differentiation of stem cells for bone tissue engineering. ACS Biomater Sci Eng. 2020;6(11):6284-6295.

28. Variola F, Yi JH, Richert L, Wuest JD, Rosei F, Nanci A. Tailoring the surface properties of Ti6Al4V by controlled chemical oxidation. Biomaterials. 2008;29(10):1285-1298.

29. Bose S, Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012;8(4):1401-1421.

30. Surmenev RA, Surmeneva MA. Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis: a review. Acta Biomater. 2014;10(2):557-579.

31. Shi X, Zhou K, Huang F, Wang C. Interaction of hydroxyapatite nanoparticles with endothelial cells: internalization and inhibition of angiogenesis in vitro through the PI3K/Akt pathway. Int J Nanomedicine. 2017;12:5781-5795.

32. Baino F, Hamzehlou S, Kargozar S. Bioactive glasses: where are we and where are we going? J Funct Biomater. 2018;9(1):25.

33. Ramazanoglu M, Oshida Y. Osseointegration and bioscience of implant surfaces: current concepts at bone-implant interface. In: Turkyilmaz I, editor. Implant Dentistry - A Rapidly Evolving Practice. Rijeka: InTech; 2011. p. 57-82.

34. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials. 2010;31(24):6279-6308.

35. Beederman M, Lamplot JD, Nan G, Wang J, Liu X, Yin L, et al. BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng. 2013;6(8A):32-52.

36. Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res. 2011;29(12):1795-1803.

37. Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91:30-38.

38. Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15(7):757-765.

39. Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface. 2011;8(55):153-170.

40. Vo TN, Kasper FK, Mikos AG. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev. 2012;64(12):1292-1309.

41. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol. 2000;71(8):1241-1257.

42. Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol. 2005;76(12):2205-2215.

43. Simion M, Rocchietta I, Kim D, Nevins M, Fiorellini J. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model. Int J Periodontics Restorative Dent. 2006;26(5):415-423.

44. Levi B, Longaker MT. Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells. 2011;29(4):576-582.

45. Kawecki M, Łabuś W, Klama-Baryla A, Kitala D, Kraut M, Glik J, et al. A review of decellurization methods caused by an urgent need for quality control of cell-free extracellular matrix' scaffolds and their role in regenerative medicine. J Biomed Mater Res B Appl Biomater. 2018;106(2):909-923.

46. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000;97(25):13625-13630.

47. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 2007;13(5):947-955.

48. Gao C, Deng Y, Feng P, Mao Z, Li P, Yang B, et al. Current progress in bioactive ceramic scaffolds for bone repair and regeneration. Int J Mol Sci. 2014;15(3):4714-4732.

49. Diomede F, Gugliandolo A, Cardelli P, Merciaro I, Ettorre V, Traini T, et al. Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles: a new tool for bone defect repair. Stem Cell Res Ther. 2018;9(1):104.

50. Gómez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C, Gerbhard F. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015;70:93-101.

51. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87(7):1430-1437.

52. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35-42.

53. Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824-833.

54. Kaigler D, Pagni G, Park CH, Braun TM, Holman LA, Yi E, et al. Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplant. 2013;22(5):767-777.

55. Gjerde C, Mustafa K, Hellem S, Rojewski M, Gjengedal H, Yassin MA, et al. Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial. Stem Cell Res Ther. 2018;9(1):213.

56. Albrektsson T, Wennerberg A. Oral implant surface topography: a review. Int J Oral Maxillofac Implants. 2004;19(2):147-154.

57. Wennerberg A, Albrektsson T. Effects of titanium surface topography on bone integration: a systematic review. Clin Oral Implants Res. 2009;20 Suppl 4:172-184.

58. Smeets R, Stadlinger B, Schwarz F, Beck-Broichsitter B, Jung O, Precht C, et al. Impact of dental implant surface modifications on osseointegration. Biomed Res Int. 2016;2016:6285620.

59. Gittens RA, Scheideler L, Rupp F, Hyzy SL, Geis-Gerstorfer J, Schwartz Z, et al. A review on the wettability of dental implant surfaces II: biological and clinical aspects. Acta Biomater. 2014;10(7):2907-2918.

60. Davies JE. Understanding peri-implant endosseous healing. J Dent Educ. 2003;67(8):932-949.

61. Mavrogenis AF, Dimitriou R, Parvizi J, Babis GC. Biology of implant osseointegration. J Musculoskelet Neuronal Interact. 2009;9(2):61-71.

62. Dohan Ehrenfest DM, Coelho PG, Kang BS, Sul YT, Albrektsson T. Classification of osseointegrated implant surfaces: materials, chemistry and topography. Trends Biotechnol. 2010;28(4):198-206.

63. Le Guéhennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23(7):844-854.

64. Javed F, Romanos GE. The role of primary stability for successful immediate loading of dental implants: a literature review. J Dent. 2010;38(8):612-620.

65. Chrcanovic BR, Albrektsson T, Wennerberg A. Bone quality and quantity and dental implant failure: a systematic review and meta-analysis. Int J Prosthodont. 2017;30(3):219-237.

66. Kulkarni M, Mazare A, Gongadze E, Perutkova Š, Kralj-Iglič V, Milošev I, et al. Titanium nanostructures for biomedical applications. Nanotechnology.